Ahold posts weak net profit amid tough U.S. competition

Article Abstract:

A weak showing in the U.S. market has resulted in low second-quarter net profits for Dutch retailer Koninklijke Ahold NV. The one bright spot among Ahold's U.S. subsidiaries is the earnings at its U.S. Foodservice unit. Meanwhile, in Europe, Ahold's operating income has more than doubled. The retailer currently faces investigation from regulatory agencies in the U.S. and Holland due to an accounting scandal.

United States, Legal issues & crime, Netherlands, Foreign operations, Sales, profits & dividends, FOOD AND KINDRED PRODUCTS, Executive changes & profiles, Parent-to-subsidiary activities, Subsidiary-to-parent activities, Officials and employees, Company legal issue, Food industry, Investigations, Appointments, resignations and dismissals, Company sales and earnings, Company earnings/profit, Koninklijke Ahold N.V., U.S. Foodservice, Food and beverage production/distribution software, Subsidiaries, divisions and units, Vuursteen, Karel

---

Qatar fund increases stake in J Sainsbury, fueling talk

Article Abstract:

Delta (Two) Ltd., an investment fund linked to Qatar's royal family, increased its 18% stake in J Sainsbury PLC, the British supermarket chain, to 25% for $1.44 bil. The purchase has prompted speculation of a possible takeover offer, or pressure to sell off property to return cash to the firm's shareholders.

Financial management, Investment Offices, Investment Companies, Open-End Investment Funds, Investment Funds & Trusts, Qatar, United Kingdom, Company investment, Investments, J Sainsbury PLC, Investor relations

---

Similar abstracts:

• Abstracts: Novartis posts 17% profit rise on a 12% increase in revenue. UBS is likely to post dismal results
• Abstracts: Ericsson revamps management amid intensified competition. Telia seeks to buy SBC's 41.6% stake in TeleDanmark
• Abstracts: Tesco reports slowing U.K. sales. Demand for Sainsbury offer is brisk in Euro and Sterling. Tesco and GMAC launch issues in sterling sector
• Abstracts: U.K. drug maker agrees to buy Transkaryotic. Hedge Funds vex a Shire takeover of Transkaryotic. Marconi will link ipsaris with Easynet in stock deal

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.